We demonstrated that we could recapitulate typical hallmarks of SSc, such as microvascular destabilization and sprout regression through pro-fibrotic and pro-inflammatory cytokines TGFβ and TNFα, and showed that addition of inhibitors could prevent the diseased phenotype. This evidence concerns the gene TGFB1 and systemic sclerosis.